|
| N-(3-(5-(2-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl)benzyl)-2-(pyridin-2-yl)pyriMidine-5-carboxaMide Basic information |
Product Name: | N-(3-(5-(2-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl)benzyl)-2-(pyridin-2-yl)pyriMidine-5-carboxaMide | Synonyms: | N-(3-(5-(2-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl)benzyl)-2-(pyridin-2-yl)pyriMidine-5-carboxaMide;2-(pyridin-2-yl)pyriMidine-5-carboxylic acid 3-[5-(1-hydroxy-1-Methylethyl)-1,2,4]oxadiazol-3-yl-benzylaMide;SAR191801;tert-butyl(((3aR,4R,6aR)-5-fluoro-2,2-dimethyl-6-((trityloxy)methyl)-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)diphenylsilane SAR191801;hPGDS-IN-1;SAR191801,2-Pyridin-2-yl-pyrimidine-5-carboxylic acid 3-[5-(1-hydroxy-1-methyl-ethyl)-[1,2,4]oxadiazol-3-yl]-benzylamide;N-[[3-[5-(1-Hydroxy-1-methylethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-2-(2-pyridinyl)-5-pyrimidinecarboxamide;EOS-61636 | CAS: | 1234708-04-3 | MF: | C22H20N6O3 | MW: | 416.43 | EINECS: | | Product Categories: | Inhibitors | Mol File: | 1234708-04-3.mol | |
| N-(3-(5-(2-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl)benzyl)-2-(pyridin-2-yl)pyriMidine-5-carboxaMide Chemical Properties |
density | 1.310±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | ≥ 20.6mg/mL in DMSO | form | Solid | pka | 12.34±0.46(Predicted) | color | White to off-white |
| N-(3-(5-(2-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl)benzyl)-2-(pyridin-2-yl)pyriMidine-5-carboxaMide Usage And Synthesis |
Uses | SAR191801 is a novel hematopoietic prostaglandin D synthase (hPGDS) inhibitor. |
| N-(3-(5-(2-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl)benzyl)-2-(pyridin-2-yl)pyriMidine-5-carboxaMide Preparation Products And Raw materials |
|